Luca Maccioni

620 total citations · 1 hit paper
13 papers, 402 citations indexed

About

Luca Maccioni is a scholar working on Pathology and Forensic Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Luca Maccioni has authored 13 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 10 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Luca Maccioni's work include Liver Disease Diagnosis and Treatment (10 papers), Alcohol Consumption and Health Effects (10 papers) and Gut microbiota and health (4 papers). Luca Maccioni is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Alcohol Consumption and Health Effects (10 papers) and Gut microbiota and health (4 papers). Luca Maccioni collaborates with scholars based in United States, Belgium and Germany. Luca Maccioni's co-authors include Bin Gao, Yaojie Fu, Bryan Mackowiak, Peter Stärkel, Isabelle Leclercq, Bernd Schnabl, Sophie Leclercq, Yves Horsmans, Philippe de Timary and Bei Gao and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Luca Maccioni

10 papers receiving 399 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Alcohol-associated liver disease

2024 157 citations Bryan Mackowiak, Yaojie Fu et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Luca Maccioni

Since Specialization

Citations

This map shows the geographic impact of Luca Maccioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Maccioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Maccioni more than expected).

Fields of papers citing papers by Luca Maccioni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Maccioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Maccioni. The network helps show where Luca Maccioni may publish in the future.

Co-authorship network of co-authors of Luca Maccioni

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Maccioni. A scholar is included among the top collaborators of Luca Maccioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Maccioni. Luca Maccioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders 2025 ·Journal of Medicinal Chemistry ·(unknown), Szabolcs Dvorácskó, (unknown), (unknown), (unknown), Luca Maccioni, Grzegorz Godlewski, Tony Jourdan, Sergio A. Hassan, Reşat Çınar, Malliga R. Iyer	0
2	The Link between Alcohol Consumption and Kidney Injury 2025 ·American Journal Of Pathology ·(unknown), Luca Maccioni, (unknown), György Haskó, Laura E. Nagy, Bin Gao, Pál Pacher	0
3	3D fluorescence staining and confocal imaging of low amount of intestinal organoids (enteroids): Protocol accessible to all 2025 ·PLoS ONE ·(unknown), Caroline Bouzin, (unknown), Luca Maccioni, Peter Stärkel	0
4	Alcohol-associated liver disease breakdown → 2024 ·Journal of Clinical Investigation ·Bryan Mackowiak, Yaojie Fu, Luca Maccioni, Bin Gao	157
5	Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets 2024 ·Cellular and Molecular Gastroenterology and Hepatology ·Dechun Feng, Seonghwan Hwang, Adrien Guillot, Yang Wang, Yukun Guan, Cheng Chen, Luca Maccioni, Bin Gao	14
6	Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages 2023 ·Alcohol Clinical and Experimental Research ·Luca Maccioni, Yves Horsmans, Isabelle Leclercq, Bernd Schnabl, Peter Stärkel	6
7	Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans 2023 ·Hepatology Communications ·Luca Maccioni, (unknown), Sophie Leclercq, (unknown), Géraldine Laloux, Yves Horsmans, Isabelle Leclercq, Bernd Schnabl, Peter Stärkel	7
8	Alcohol-associated bowel disease: new insights into pathogenesis 2023 ·SHILAP Revista de lepidopterología ·Luca Maccioni, Yaojie Fu, Yves Horsmans, Isabelle Leclercq, Peter Stärkel, George Kunos, Bin Gao	31
9	Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: A pilot randomized, double-blind, placebo-controlled study 2022 ·EBioMedicine ·Camille Amadieu, Luca Maccioni, Sophie Leclercq, Audrey M. Neyrinck, Nathalie M. Delzenne, Philippe de Timary, Peter Stärkel	16
10	Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder 2022 ·Metabolites ·Bei Gao, Su-Ling Zeng, Luca Maccioni, (unknown), Aaron M. Armando, Oswald Quehenberger, Xinlian Zhang, Peter Stärkel, Bernd Schnabl	6
11	Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol‐associated liver disease in humans 2022 ·Alimentary Pharmacology & Therapeutics ·Luca Maccioni, Axelle Loriot, Joseph P. Dewulf, Guido T. Bommer, Yves Horsmans, Nicolas Lanthier, Isabelle Leclercq, Bernd Schnabl, Peter Stärkel	10
12	Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans 2020 ·Gut Microbes ·Luca Maccioni, Bei Gao, Sophie Leclercq, (unknown), Yves Horsmans, Philippe de Timary, Isabelle Leclercq, Derrick E. Fouts, Bernd Schnabl, Peter Stärkel	130
13	Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis 2019 ·Hepatology Communications ·Peter Stärkel, Bernd Schnabl, Sophie Leclercq, Mina Komuta, Ramón Bataller, Josepmaria Argemí, Elena Palma, Shilpa Chokshi, Claus Hellerbrand, Luca Maccioni, Nicolas Lanthier, Isabelle Leclercq	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact